Indian J Med Microbiol Close
 

Results of Phase III chemotherapy trials using regimens based on tubule inhibitors for hormone-resistant prostate cancer

Results of Phase III chemotherapy trials using regimens based on tubule inhibitors for hormone-resistant prostate cancer